Edition:
India

Acasti Pharma Inc (ACST.OQ)

ACST.OQ on NASDAQ Stock Exchange Capital Market

0.56USD
20 Jul 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.56
Open
$0.55
Day's High
$0.56
Day's Low
$0.55
Volume
14,412
Avg. Vol
43,794
52-wk High
$3.34
52-wk Low
$0.54

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.20 March 21 Jul 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 2 2 2 2
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.67 1.67 1.67 1.67

Consensus Estimates Analysis

Sales and Profit Figures in 
Earnings and Dividend Figures in 
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Feb-18 2 0.00 0.00 0.00 --
Year Ending Feb-18 2 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Feb-18 1 -0.20 -0.20 -0.20 --
Year Ending Feb-18 2 -0.64 -0.29 -0.98 --

Historical Surprises

Sales and Profit Figures in 
Earnings and Dividend Figures in 
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Nov-14 0.27 0.02 0.25 91.10
Earnings (per share)
Quarter Ending Nov-14 -0.27 0.25 0.52 -191.90

Consensus Estimates Trend

Sales and Profit Figures in 
Earnings and Dividend Figures in 
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Feb-18 0.00 -- -- -- --
Year Ending Feb-18 0.00 -- -- -- --
Earnings (per share)
Quarter Ending Feb-18 -0.20 -- -- -- --
Year Ending Feb-18 -0.64 -- -- -- --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Feb-18 -- -- -- --
Year Ending Feb-18 -- -- -- --
Earnings
Quarter Ending Feb-18 -- -- -- --
Year Ending Feb-18 -- -- -- --